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Abstract
Background: Campylobacter infection is the most common cause of bacterial gastroenteritis in developing
countries, including Madagascar. Reports of pathogenicity have not been consistent and repeated exposures over
time seem to lead to the development of protective immunity in developing areas. We conducted this study to
support evidence for these hypotheses by exploring the association between infection and age, the reoccurrence
of infection and the pathogenicity of Campylobacter.
Methods: We carried out a community-based longitudinal study of children under the age of 24 months in two
rural villages in Moramanga, Madagascar. Children were visited twice a week and a stool specimen was collected in
cases of diarrhoea. Stools specimens were collected bimonthly from all children enrolled, regardless of symptoms.
Children were followed-up until the age of 36 months.
Results: Between January 2010 and May 31st 2012, 508 children were included in the cohort. We detected 319
episodes of Campylobacter infection in total, and 43.3% (n = 220) of the children had at least one episode of
intestinal Campylobacter infection. The rate of Campylobacter isolation from stool specimens was 9.3%. The annual
incidence rate for symptomatic Campylobacter infection was 0.05 episodes/child. The probability of Campylobacter
infection was highest between the ages of six and 23 months. Taking children under six months of age as the
reference group, the age-specific odds ratio for the association was 5.0 (95% CI: 2.9-8.6) for children aged six to
11 months, 5.7 (95% CI: 3.3-10.0) for children aged 12 to 17 months and 3.3 (95% CI: 1.8-5.8) for children aged 18 to
23 months. A second episode of infection occurred 63 days after the first episode in children with primary infections,
and after 137 days in children with multiple infections (p < 0.01). First episodes of Campylobacter infection were
associated with diarrhoea (odds ratio = 16.1; 95% CI: 1.8-140.8).
Conclusion: Our findings suggest that protective immunity to Campylobacter may be acquired over time, following
repeated exposures. However, Campylobacter infection prevention measures should be reinforced in the first year of
life, as this age seems to be associated with the highest risk of diarrhoea during Campylobacter infection.
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Background
Although, diarrhoea-related mortality is decreasing world-
wide since the introduction of oral rehydration therapy, it
remains high. In Africa, the estimated annual reduction of
diarrhoeal deaths since 2000 was about 4% per year [1]. In
total 3.6 million children each year die before reaching
their fifth birthday in Africa, and diarrhoeal disease
accounts for 11% of these deaths [1]. Disease morbidity
and the incidence of diarrhoea in particular, are declining
more modestly [2]. The importance of pathogens such as
rotavirus and Escherichia coli in the aetiology of severe
childhood diarrhoea in developing countries is well recog-
nised [3,4]. However the role of Campylobacter is not well
understood either in the community setting or in hospita-
lised subjects and outpatients.
The epidemiological features of Campylobacter infec-
tion differ between developed and developing countries.
Campylobacter is endemic to developing countries, where
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it is, one of the most frequently isolated bacteria from
both diarrhoeic and non-diarrhoeic children [5]. Current
estimates of the proportion of diarrhoea cases attributable
to Campylobacter infection are derived from a small num-
ber of studies, but it is believed to be high, between 5 and
20% [5]. A case-control study for diarrhoea was conducted
in 14 districts of Madagascar in 2008 in children under-
five, by the Pasteur Institute of Madagascar [6]. Its find-
ings suggested that Campylobacter was the second most
frequently isolated enteropathogen, after parasites, in chil-
dren under the age of five years, with a prevalence of
9.7%. However, its frequency did not differ between cases
and control subjects.
Many studies have suggested that the development of
protective immunity in children from developing coun-
tries may account for the high rates of asymptomatic
Campylobacter infection and for the decrease in the pro-
portion of infected subjects presenting illness with in-
creasing age [7,8]. Campylobacter isolation rates are
highest during the first two years of life and appear to
decline with age [5,9]. The development of immunity
might also affect the recurrence of infection. Immunity
following a first episode of campylobacteriosis might de-
crease the risk of subsequent events, which might also
vary over time and with patient characteristics [10].
In 2008, the cross-sectional study [6] conducted in
Malagasy children under-five have not found an associ-
ation between Campylobacter infection and occurrence
of diarrhoea. Thus, we investigated the pathogenicity of
Campylobacter through a cohort study and assessed the
hypothesis of the development of immunity after Campylo-
bacter infection in Madagascar. We conducted the study
in young children under the age of 36 months, known as
the age at higher risk of Campylobacter infection.
Methods
Setting and study population
This study was conducted in the low-income rural areas
of Befotsy and Ampitambe, Moramanga, in the middle
of the eastern region of Madagascar. These two villages
were the pilot areas of the Health and Demographic Sur-
veillance Site of Moramanga (HDSS Moramanga) and
were investigated during the case-control study carried
out in 2008 [6]. The highest prevalence of Campylobac-
ter infection in children with diarrhoea was found in the
district of Moramanga (20.7%). The prevalence of Cam-
pylobacter was 20% in Befotsy and 10% in Ampitambe.
The local population is 4231 inhabitants, most of whom
are engaged in agricultural activities. The 1006 house-
holds lack basic sanitary facilities, use water from the
river or a traditional well for drinking and often have
free-range domestic chickens at home; the risk of faecal
contamination of the environment is therefore likely to
be high.
Cohort enrolment
We used data from HDSS Moramanga, in which lon-
gitudinal demographic surveillance was carried out on
the population of four communities in the district of
Moramanga. The HDSS Moramanga conducted a door-
to-door census, and collected demographic data and data
for each individual household in the two villages at a given
time point (water supply, goods, ownership of animals,
etc…). Children under the age of 24 months living in ei-
ther of the two villages were eligible for enrolment in this
study. An open cohort of children enrolled before the age
of 24 months was followed up from January 2010 to May
2012. All the children were monitored until the age of
36 months. Children who moved within the study area
were followed up at their new homes, whereas those who
moved outside the study area were withdrawn from the
study. On enrolment, an interview was conducted with
one of the child’s parents, to obtain information about the
child, including breastfeeding and nutritional status. Each
of the children enrolled provided a stool specimen for the
isolation of Campylobacter spp. Enrolment continued
throughout the study, for new infants born into a house-
hold and for young children moving into the village.
Surveillance activities
Twice a week diarrhoeal surveillance
From the day of enrolment in the study until 36 months
of age, a study physician and a locally recruited commu-
nity health worker (CHW) visited each of the children
twice a week at their homes. The children’s mothers
were asked about any episodes of diarrhoea since the last
visit. If a child had diarrhoeal illness, the physician car-
ried out clinical and anthropometric examinations, col-
lected a stool sample for Campylobacter culture and
provided oral rehydration therapy and/or other treat-
ment if indicated. Treatment was given in accordance
with Ministry of Health guidelines. Antimicrobial treat-
ment was provided if diarrhoea was associated with fever
or blood/mucus in the stools. A pictorial diarrhoea diary
was given to the mothers of children with diarrhoea, for
recording the number of bowel movements and the
consistency of the faeces, from the first day of diarrhoea
until its cessation. Movements of children to areas out-
side the study area, deaths and other losses to follow-up
were recorded by the CHW during the twice a week
visits.
Bimonthly surveillance
We also carried out a cross-sectional surveillance. All
children included in the cohort, regardless of their history
of diarrhoea, were surveyed once every two months
(60 days), with the collection of a stool specimen for Cam-
pylobacter isolation. In these surveys, weight and length/
height data were also collected. This cross-sectional study
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provided us with data on asymptomatic Campylobacter
infection.
These surveillance activities were performed for the
purposes of this study only.
Definitions
– A day with diarrhoea was defined as a 24-hour
period in which three or more loose stools taking
the form of the container or any number of stools
containing blood were obtained [11]. For small,
exclusively breastfed children, if the stools were not
bloody, diarrhoea was defined as an increase in the
frequency or a reduction of the consistency of the
stools with respect to what the mother considered
normal for her child.
– Episodes of diarrhoeal illness were defined using a
minimum three-day diarrhoea-free gap to mark the
beginning of a new episode.
– Campylobacter infection was defined as
symptomatic if Campylobacter was isolated from
diarrhoeal stools or within a period of five days
before and after an episode of diarrhoea.
– Campylobacter infection was defined as
asymptomatic if there were at least five consecutive
symptom-free days before and after the isolation of
Campylobacter from faeces.
– The days at risk included the three-day period
following the occurrence of an episode of diarrhoea.
– Primary Campylobacter infection was defined as the
first isolation of Campylobacter from a stool
specimen collected during enrolment, or at the
twice a week or bimonthly surveillance visits, from a
child enrolled within 28 days of birth.
– Multiple Campylobacter infections were defined as
the isolation of Campylobacter from a stool
specimen collected during enrolment, or at the
twice a week or bimonthly surveillance visits, from a
child enrolled after the age of 28 days.
Microbiological analyses
For the isolation of Campylobacter spp., we cultured
fresh faecal specimens from children with and without
diarrhoea directly in the field on selective agar plates
(Karmali). Plates were incubated at 37°C under micro-
aerophilic conditions (Campygen, Oxoid France) for 48
to 72 hours. The identification of Campylobacter isolates
was confirmed with the Campy dry spot kit, a haem-
agglutination test from Oxoid (England), as recom-
mended by the manufacturer. We differentiated between
Campylobacter jejuni (C. jejuni), Campylobacter coli (C.
coli) and other species by the multiplex polymerase
chain reaction (PCR) method [12]. This differentiation
was conducted on 271 samples of Campylobacter iso-
lates selected at random.
Data analysis
We analysed data from 19th January 2010 until 31st May
2012. Person-time at risk was calculated as the observed
number of days at risk between episodes. Incidence rates
were calculated by dividing the number of episodes by
the number of child-years of observation. We estimated
the incidence rates for diarrhoea and symptomatic infec-
tion. Children were assigned to age groups: 0 to 5 months,
6 to 11 months, 12 to 17 months, 18 to 23 months, 24 to
29 months and 30 to 36 months. This classification of age
group was chosen in accordance with our hypothesis that
exposure and infection risk vary with age.
Anthropometric measurements were transformed into
weight-for-height/length, height/length-for-age and weight-
for-age Z scores based on WHO standard reference popu-
lation. Stunting, wasting and underweight were defined as
height/length-for-age, weight-for-height/length and weight-
for-age less than -2 standard-deviations from the refer-
ence standards for children of the same age and sex,
respectively [13].
Association between infection and age
At the time of enrolment
The Chi-squared test was used to measure associations
between Campylobacter infection and age group at the
time of enrolment. If a significant result was obtained by
the Chi-squared test, we assessed the strength of associ-
ation between Campylobacter infection and age group at
the time of enrolment by logistic regression. The unit of
analysis was the individual child. Data collected at the
time of enrolment were used, with age group considered
as the explanatory variable and the infection status of
the faecal specimen as the outcome.
During follow-up
During follow-up, the association of Campylobacter in-
fection and symptomatic Campylobacter infection with
age group was assessed with a logistic mixed regression
model. The outcome variable was Campylobacter infec-
tion or symptomatic Campylobacter infection status,
and age group was the main explanatory variable. For
the two analyses, we incorporated socioeconomic and
household data collected at the time of enrolment, nutri-
tional status data obtained during enrolment and follow-
up as potential confounding variables. We included in
the mixed models all potential confounding variables
with a p-value <0.2 in the univariate analyses. We then
used backward elimination to identify confounding vari-
ables for inclusion in the final model. A Wald Chi-
squared test was used to assess the significance of each
of the variables tested and odds ratios were calculated to
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quantify their effects. The follow-up visits for a given
child were not statistically independent entities. We
therefore took into account the correlation between re-
peated observations for each individual, between mul-
tiple children living in the same household and in the
same village. Thus, for the two mixed models, we added
each observation for each child, household and village as
a random effect. The use of a random effect made it
possible to adjust for the correlation between data ob-
tained from the same individual, the same household or
the same village and to measure the variability between
these data.
The unit of analysis was the individual visit, with the
collection of a stool sample, for investigations of the re-
lationship between Campylobacter infection and age. For
analysis of the relationship between symptomatic Cam-
pylobacter infection and age, we considered each visit at
which a diarrhoeal stool sample was obtained (diarrhoeal
episode) as the unit of analysis. We took the 0-5 months
age group as the reference group.
Data for Campylobacter infection status (overall infec-
tion, symptomatic infection) were obtained at the time
of enrolment, and at the twice a week and bimonthly
surveillance visits.
Pathogenicity of Campylobacter
The association between Campylobacter infection and
diarrhoeal episodes was investigated with logistic regres-
sion models. This analysis was performed on newborns
enrolled within 28 days of birth. Children with diarrhoea
were considered as the outcome, with Campylobacter in-
fection as the explanatory variable.
Recurrent episodes
Survival analysis was used to assess the time to recurrent
episodes of Campylobacter in children with primary in-
fection and those with multiple infection. We used log-
rank tests to compare the two Kaplan-Meier survival
curves. We used Cox proportional hazard models to as-
sess the extent to which the timing of recurrent episodes
could be explained by potential confounders. Time to
event was estimated as the interval between the first and
second episodes of infection.
Data were analysed with R software version 2.12.1 (R
Development Core Team (2007). For all statistical tests, a
p-value below 0.05 was considered statistically significant.
Ethics
Written informed consent was obtained from the parent
or guardian of each child before enrolment. The study
was approved by the National Ethics Committee of the
Ministry of Health of Madagascar (Number 002-CE/
MINSAN – 01/13/2012).
Results
We recruited 210 children at the start of the study.
Thereafter, 68 new births, 54 immigrants to the study
and 176 children included after the age of 28 days were
enrolled. The mean age of children at the start of the
study was 11.7 months (standard deviation: 7.4; range:
0.2-23 months; median: 11.6 months). During the obser-
vation period, four children died from causes other than
diarrhoea during their first year of life and 68 (13.4%)
dropped out of the study due to a withdrawal of consent
(22/508) or migration out of the study area (46/508).
The study population comprised 508 children, who were
followed for a total of 256,366 child-days (702.4 child-
years). The median follow-up time was 505.7 days
(interquartile range [IQR]: 373 days). The cohort of 508
children consisted of 259 girls and 249 boys (male/fe-
male ratio = 0.9). The characteristics of the cohort chil-
dren were shown in Table 1.
Over the two 2-year study period, 3424 stool samples
were tested for Campylobacter. In total, 2965 (87%) of
these samples were collected from children without diar-
rhoea during the cross-sectional survey, which was con-
ducted at two-month intervals. The rate of Campylobacter
isolation from all samples was 9.3% (319/3424): 8.9% (41/
459) from diarrhoeic samples and 9.4% (278/2965) in
non-diarrhoeic samples. Overall, 43.3% (220/508) of chil-
dren had at least one Campylobacter infection; 16.4% (36/
220) of the infected children had diarrhoea and 32.3% (71/
220) had more than one episode of Campylobacter infec-
tion. Overall, 13.9% (71/508) of all children had more than
one episode of infection. Identification to the species level
was carried out for 271 of the 319 Campylobacter isolates:
190 (70.1%) were C. jejuni, 64 (23.6%) were C. coli and 17
(6.3%) belonged to other species. There were no statisti-
cally significant difference between the isolation rate of C.
jejuni and C. coli from diarrhoeal and non-diarrhoeal sam-
ples (p = 0.16, Chi-squared test). We found that children
infected with C. jejuni were likely to have subsequent in-
fection than those infected with C.coli (p = 0.002, Chi-
squared test): 4.7% (3/64) of children infected with C. coli
and 21.6% (39/180) of those infected with C. jejuni had
subsequent infection. Campylobacter isolation rates from
diarrhoeic and non-diarrhoeic samples, by age group, are
shown in Table 2.
At the time of enrolment, 6.3% (n = 32) of the chil-
dren were already infected with Campylobacter: 6.2% (2/32)
were symptomatic and the remaining (30/32) children
were asymptomatic. The prevalence of Campylobacter
infection, by age group, at the time of enrolment was
4.6% (17/369) for children under 12 months of age and
10.8% (15/139) for children aged 12 months or older.
The frequency of Campylobacter infection at the time of
enrolment differed significantly between age groups
(Chi-squared test, p < 0.001). The age-specific odds ratios
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for Campylobacter infection at the time of enrolment
were 8.6 (95% confidence interval [CI]: 3.0-24.1), 5.9
(95% CI:1.9-18.3), 5.7 (1.9-17.2) for the 6-11 month, 12-17
month and 18-23 month age groups, respectively.
The probability of infection during follow-up varied
with age. In the logistic mixed model, taking children
under six months of age as the reference group, the odds
of being infected with Campylobacter were five times
higher in children aged between six and 18 months, the
odds ratio were 5 (95% CI: 2.9-8.6) for children aged six
to 11 months and 5.7 (95% CI: 3.3-10) for those aged 12
to 17 months (Table 3). The association for living in a
household that owned livestock (versus living in a
household that did not own livestock) was of borderline
significance (odds ratio: 1.3; 95% CI: 1.0-1.7). The vari-
ables with a p-value below 0.2 included in the mixed re-
gression model were the construction of a floor, the
ownership of goods, domestic animals, livestock and the
availability of toilets. An additional file shows the result of
univariate analysis in more detail [see Additional file 1].
Antimicrobial treatments were given to children with
diarrhoea who had fever and to children with blood or
mucus in their faeces. Antimicrobial treatment was given
to 18.5% (85/459) of patients with diarrhoeal episodes
due to fever and to 17.8% due to the presence of blood
or mucus in the faeces (3.1% for blood and 14.8% for
mucus in the faeces). Mild dehydration was observed in
four episodes of diarrhoea.
We observed 475 diarrhoeal episodes with a median
duration of 4.5 days (IQR: 5 days), resulting in an annual
incidence rate of 0.7 episodes/child (95% CI: 0.7-0.8 epi-
sodes/child). We were able to collect stool samples for
96.6% (459/475) of all diarrhoeal episodes. Overall, 53.7%
(n = 273) of the children presented at least one episode of
diarrhoea during the observation period. The highest inci-
dence rates were obtained for children under the age of
12 months. The annual incidence was 0.8 episodes/ child
(95% CI: 0.7-0.9 episodes/child) in children aged 0 to
11 months and 0.5 episodes/child (95% CI: 0-0.6 episodes/
child) for children over the age of 12 months.
The overall annual incidence of symptomatic Cam-
pylobacter infections was 0.05 episodes/child. The me-
dian duration of symptomatic Campylobacter infection
Table 1 Characteristics of the cohort children during a
28-month longitudinal community study of Campylobacter
infection, Moramanga, 2010-2012
Characteristics N (%)
Demographic data n = 508
Sex Male 249 (49.0)
Female 259 (51.0)
Age group (months) < 6 295 (58.1)
6-11 74 (14.5)
12-17 64 (12.6)
18-23 75 (14.7)
Nutritional status data n = 506
Stunting Yes 151 (29.8)
No 355 (70.2)
Underweight Yes 46 (9.1)
No 460 (81.9)
Wasting Yes 5 (0.9)
No 501 (99.1)
Households data n = 439
Number of persons/room (mean ± SD) 3.7 (±1.7)
Floor Concrete 271 (67.1)
Mud 168 (32.9)
Cooking area Yes 411 (80.9)
No 28 (19.1)
Shower area Yes 50 (11.4)
No 389 (88.6)
Latrin Yes 281 (64.0)
No 158 (36.0)
Domestic animals Yes 134 (30.5)
No 305 (69.5)
Livestock # Yes 109 (24.8)
No 330 (75.2)
Fowl§ Yes 279 (63.5)
No 160 (36.5)
Goods£ Yes 434 (98.8)
No 5 (1.2)
Source of drinking water Tubewell, borehole 201 (45.8)
Surface waters 239 (54.2)
Water drinking storage Protected 139 (31.6)
Unprotected 300 (68.4)
Garbage in the concession Yes 222 (50.6)
No 217 (49.4)
Data about mother n = 416
Age (years) (mean ± SD) 28.3 (±9)
Maternal education Primary 294 (70.7)
Secondary 91 (21.9)
Table 1 Characteristics of the cohort children during a
28-month longitudinal community study of Campylobacter
infection, Moramanga, 2010-2012 (Continued)
Superior 4 (0.9)
No education 27 (6.5)
SD: standard-deviation.
#Ownership of one of the following: cow, ox, sheep, pig, rabbit.
§Ownership of one of the following: chicken, duck, goose.
£Ownership of one of the following: radio, television, bicycle, sewing machine,
mobile phone, rice fields, house.
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was five days, with an IQR of 4.3 days. The mean age for
symptomatic Campylobacter infection was 13.8 months
(standard deviation: 7.1; range: 2.7-33.8 months; median:
11.8 months). Among the children with diarrhoea, 13.2%
(36/273) excreted Campylobacter and 16.7% (6/36) re-
ceived antimicrobial treatments. The frequency of symp-
tomatic Campylobacter infections did not differ between
age groups (p = 0.3, Wald z-statistic test).
Campylobacter was isolated from 201(39.6%) asymp-
tomatic children. The mean age for asymptomatic Cam-
pylobacter infection was 14.7 months (standard deviation:
7; range: 1.3-35.2 months; median: 13 months).
There was a statistically significant association be-
tween Campylobacter primary infection and diarrhoea
(p < 0.001, Wald z-statistics test). In the birth cohort of
64 children, the odds ratio for shedding Campylobacter
for the first time among children with diarrhoea was
16.1 (95% CI: 1.8-140.8), taking children without diar-
rhoea as the reference group.
Infection recurred more rapidly in children with pri-
mary infections than in those with multiple infections:
25% of children with primary infections had their second
infection episode 63 days after the first episode, whereas
the second episode occurred after 317 days after the first
episode in children with multiple infections (p < 0.01,
log-rank test). Figure 1 shows the survival curves for re-
current infection over time for the two groups. We
found that children with primary infection living in a
household that have mud flooring was 6.1 times at risk
(hazard-ratio: 6.1, CI 95%: 1.4-25.5) to have recurrent in-
fections more rapidly than those living in household
with floor made with concrete materials (cement, tiles).
Discussion
To our knowledge, this is the first cohort study on diar-
rhoea in children in Madagascar.
Our results provide an indication of the role of the im-
munity on the occurrence of Campylobacter infection in
children in Moramanga, as we observed an age-related
decrease in infection rates and the time to recurrence
was shorter in children with primary infections than in
those with multiple infections. Our data also suggest
that the first Campylobacter infection was associated to
diarrhoea.
We found an association between age group and infec-
tion, as reported in other developing countries [14,15],
Table 2 Rate of isolation of enteric Campylobacter from diarrhoeic and non-diarrhoeic samples, Moramanga, 2010-2012
Number of positive samples
Diarrhoeal stools Non-diarrhoeal stools
Age group Child-days
at risk
Number of
episodes
Number
positive (%)
Number
of tests
Number
positive (%)
Number of
infections
0-5 months 27,616 64 4 (6.2) 564 14 (2.5) 18
6-11 months 77,208 171 16 (9.3) 641 93 (14.5) 109
12-17 months 68,184 102 10 (9.8) 557 90 (16.1) 100
18-23 months 25,146 64 6 (9.4) 535 46 (8.6) 52
24-29 months 30,859 40 4 (10.0) 399 22 (5.5) 26
30-36 months 27,353 18 1 (5.5) 269 13 (4.8) 14
Total 256,366 459 41 (8.9) 2965 278 (9.4) 319
Table 3 Associations of Campylobacter infection with age group during follow-up, mixed logistic regression model,
Moramanga, 2010-2012
Confounding variables Presence of Campylobacter Crude OR Adjusted OR*
Yes No
Age group < 6 months 16 (3.0)§ 521 (97.0)§ Reference Reference
6-11 months 94 (13.1) 619 (86.9) 4.9 (2.7-8.9)† 5.0 (2.9-8.6)†
12-17 months 90 (15.0) 509 (85.0) 6.0 (3.3-10.9) 5.7 (3.3-10.0)
18-23 months 51 (9.0) 514 (91.0) 3.3 (1.8-5.9) 3.3 (1.8-5.8)
24-29 months 25 (6.0) 396 (94.0) 2.2 (1.2-4.0) 2.1 (1.1-4.0)
30-36 months 14 (4.9) 272 (95.1) 1.8 (0.8-3.9) 1.6 (0.8-3.4)
Total 290 2831
†Numbers in brackets, 95% confidence interval; OR: odds ratio.
§Numbers in brackets, percentage.
*Adjusted for the ownership of livestock, mixed models were generated from 3121 observations.
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with infection rates increasing up to the age of six
months and then decreasing after 30 months. In our co-
hort of children, immunity seemed to decrease the prob-
ability of acquiring infection in response to further
exposures over time [16,17]. The shorter time to recur-
rence of infection in children with primary infection
may reflect the immature and naive nature of the immune
system in this group. The immune system is known to be
immature at birth, with microbial colonization of the in-
testine playing a role in the maturation of the immune cell
response [18,19]. Repeated exposures may be required to
achieve immunity. Prior immunity has also been demon-
strated to be important for protection against Campylo-
bacter in other studies [20]. The first primary infection in
our study occurred at the age of five months, suggesting a
contribution of antibody transfer from the mother during
the first five months of life. Susceptibility to Campylobac-
ter infection in early infancy may thus be reduced by the
acquisition of passive immunity from placentally trans-
ferred antibodies from immune mothers [17]. A previous
study conducted in the Central African Republic also sug-
gested a protective role for maternal antibodies. Children
who had Campylobacter infections during the first six
months of life had significantly fewer anti-flagellum anti-
bodies at birth than those who did not have Campylobac-
ter infections during this period [21,22]. Breastfeeding
may also affect the development of immunity during early
infancy; data about breastfeeding were not available during
the follow-up period. We found that for children with pri-
mary infection, living in a household that have mud floor-
ing is associated with an increased risk of having recurrent
episodes. A mud flooring habitation may be considered as
a proxy of a low socio-economic status of the household,
human Campylobacter infection was already reported to
be associated with poverty [15]. Our observation may also
suggest that there is a risk of Campylobacter transmission
in environments where there may be a poor hygiene
conditions.
We conclude that the first Campylobacter infection
was pathogenic. An analysis performed in a subset of the
cohort, in newborns enrolled during the first 28 days of
life, corroborated this finding. Reports of the pathogen-
icity of Campylobacter in different studies from around
the developing world have not been consistent [7,8,15].
The development of diarrhoea during Campylobacter in-
fection may depend on bacterial virulence and host sus-
ceptibility factors [23], and strains of Campylobacter
may differ in pathogenicity. There may also be animal
host-adapted genotypes that never or rarely cause diar-
rhoea in humans [24]. Despite the many studies carried
out on Campylobacter, we still need to elucidate the
mechanism by which Campylobacter causes diarrhoea in
humans and its interaction with the human immune
system.
Our data showed that species-specific immunity is less
likely to occur, however it is difficult to conclude about
species-specific resistance to reinfection as it is possible
that there was a reinfection with the same species but
with strains having different antigenic properties, thus
immunity is not effective. Strain and serotype differences
might have also an importance in protective immunity;
immunity in human seems to be serotype-specific [25],
neither genotypic nor serotyping analysis could not be
performed in this study. In addition, host-specific intes-
tinal microbiota composition may play also an important
role in the proper development of immune system.
Mechanisms underlying colonization resistance against
Campylobacter infection are multifactorial. Repeated ex-
posure is required for the generation of acquired immun-
ity, but exposure to different strains of Campylobacter and
Figure 1 Survival curves for Campylobacter infections in children with primary and multiple infections, Moramanga 2010-2012.
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overwhelming challenge may overcome immunity [21]. In
developing countries, repeated exposure may subvert
or suppress immune responses rather than leading to
protection [26].
The rate of Campylobacter isolation in our study area
was 9.3% and the annual incidence of symptomatic infec-
tion was 0.05 episodes/child. The rate of isolation of Cam-
pylobacter was lower than that reported for Peruvian
children [15] but higher than that estimated for an
Egyptian cohort [8]. However, the annual incidence of
symptomatic infection in our study was only one tenth
that reported in Peru [15], Mexico [7] and Egypt [8]. We
documented Campylobacter in 13.2% of children with
diarrhoea; this proportion has been estimated at 15.9% in
the Central African Republic [21], 3.3% in Djibouti [27]
and 0.8% in Guinea-Bissau [28]. These differences may re-
flect differences in environment, context and study design
between settings. In addition, technical difficulties in the
isolation of Campylobacter species in developing coun-
tries, due to their fastidious growth requirements and/or
the relative insensitivity of culture techniques, may influ-
ence detection rates [29]. We do not have data on the
presence of other bacterial or parasitic pathogens, thus we
are therefore unable to ascertain which pathogen is the
causative agent of the diarrhoeal episode. Assessing co-
infections were of interest as the presence of any enteric
pathogen may modulate the effect of other enteropatho-
gens during concurrent infection to modify the clinical ex-
pression. During this study, stool samples have been
stored for future testing.
In this study, we followed up a small sample of chil-
dren included before the age of 28 days. An epidemio-
logical study on this birth cohort might provide a better
assessment of the role of immunity in determining the
occurrence of infection.
We have not included in the logistic mixed model a
random-effect that account for clustering through time.
This could have an impact on our results. However, the
individual random-effect might already account for this
autocorrelation over time even if the time is not expli-
citly represented. Visits were made at regular intervals
and we have not visited many children at very short
intervals.
Conclusion
This study suggests the role of prior immunity and re-
peated exposures on the occurrence of Campylobacter
infection in children in the rural areas of Befotsy and
Ampitambe, like in the other parts of the developing
world. The association between infection and diarrhoea
during the first year of life, the effect of the quality hous-
ing and the hygiene practices on the occurrence of recur-
rent episodes highlight the need for greater awareness of
diarrhoeal disease prevention measures in infants and the
importance of controlling Campylobacter infection. Priori-
tising interventions, such as those that may improve
hygiene-related behaviors and/or the development of vac-
cines for prevalent Campylobacter serotypes, might have
an impact on diarrhoeal illnesses in the developing world.
The Moramanga HDSS constitutes a potential research
platform for Campylobacter infection studies and vaccine
trials.
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